Report Detail

Request for Sample of this report

Pharma & Healthcare Global Flu Vaccine (Influenza Vaccine) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2930121
    • |
  • 12 February, 2019
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
The worldwide market for Flu Vaccine (Influenza Vaccine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Flu Vaccine (Influenza Vaccine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine (Influenza Vaccine) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu Vaccine (Influenza Vaccine), with price, sales, revenue and global market share of Flu Vaccine (Influenza Vaccine) in 2017 and 2018.
Chapter 3, the Flu Vaccine (Influenza Vaccine) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine (Influenza Vaccine) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Flu Vaccine (Influenza Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Flu Vaccine (Influenza Vaccine) sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Flu Vaccine (Influenza Vaccine) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Whole Virus Vaccines
      • 1.2.2 Split Virus Vaccines
      • 1.2.3 Subunit Vaccines
      • 1.2.4 Live Attenuated Virus Vaccines
    • 1.3 Market Analysis by Applications
      • 1.3.1 For Children (6 months to 3 years)
      • 1.3.2 For Adults and Children over 3 years
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 CSL
      • 2.1.1 Business Overview
      • 2.1.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Sanofi Pasteur
      • 2.3.1 Business Overview
      • 2.3.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Mylan
      • 2.4.1 Business Overview
      • 2.4.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 AstraZeneca
      • 2.5.1 Business Overview
      • 2.5.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Pfizer
      • 2.6.1 Business Overview
      • 2.6.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Johnson & Johnson
      • 2.7.1 Business Overview
      • 2.7.2 Flu Vaccine (Influenza Vaccine) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Flu Vaccine (Influenza Vaccine) Market Analysis by Regions

    • 4.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 4.3 Europe Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 4.5 South America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)

    5 North America Flu Vaccine (Influenza Vaccine) by Country

    • 5.1 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
      • 5.1.1 North America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 5.3 Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)

    6 Europe Flu Vaccine (Influenza Vaccine) by Country

    • 6.1 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 6.3 UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 6.4 France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 6.5 Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 6.6 Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Flu Vaccine (Influenza Vaccine) by Country

    • 7.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
    • 7.2 China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 7.3 Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 7.4 Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 7.5 India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)

    8 South America Flu Vaccine (Influenza Vaccine) by Country

    • 8.1 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
      • 8.1.1 South America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries

    • 9.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)

    10 Global Flu Vaccine (Influenza Vaccine) Market Segment by Type

    • 10.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2014-2019)
    • 10.2 Whole Virus Vaccines Sales Growth and Price
      • 10.2.1 Global Whole Virus Vaccines Sales Growth (2014-2019)
      • 10.2.2 Global Whole Virus Vaccines Price (2014-2019)
    • 10.3 Split Virus Vaccines Sales Growth and Price
      • 10.3.1 Global Split Virus Vaccines Sales Growth (2014-2019)
      • 10.3.2 Global Split Virus Vaccines Price (2014-2019)
    • 10.4 Subunit Vaccines Sales Growth and Price
      • 10.4.1 Global Subunit Vaccines Sales Growth (2014-2019)
      • 10.4.2 Global Subunit Vaccines Price (2014-2019)
    • 10.5 Live Attenuated Virus Vaccines Sales Growth and Price
      • 10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2014-2019)
      • 10.5.2 Global Live Attenuated Virus Vaccines Price (2014-2019)

    11 Global Flu Vaccine (Influenza Vaccine) Market Segment by Application

    • 11.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2014-2019)
    • 11.2 For Children (6 months to 3 years) Sales Growth (2014-2019)
    • 11.3 For Adults and Children over 3 years Sales Growth (2014-2019)

    12 Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)

    • 12.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
      • 12.2.2 Europe Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
      • 12.2.4 South America Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
    • 12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by Type (2019-2024)
      • 12.3.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2019-2024)
    • 12.4 Flu Vaccine (Influenza Vaccine) Market Forecast by Application (2019-2024)
      • 12.4.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Flu Vaccine (Influenza Vaccine) . Industry analysis & Market Report on Flu Vaccine (Influenza Vaccine) is a syndicated market report, published as Global Flu Vaccine (Influenza Vaccine) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Flu Vaccine (Influenza Vaccine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,742.24
      		4,113.36
      		5,484.48
      		3,201.60
      		4,802.40
      		6,403.20
      		542,149.20
      		813,223.80
      		1,084,298.40
      		290,092.80
      		435,139.20
      		580,185.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo